Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations
Tomasz M Wróbel1,2, Damian Bartuzi1,3, Agnieszka A Kaczor1,4
1Department of Synthesis and Chemical Technology of Pharmaceutical Substances with Computer Modeling Laboratory, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki St., 20093 Lublin, Poland.
Journal of Chemical Information and Modeling
|September 26, 2024
Summary
Scientists identified a new binding site on CYP17A1, an enzyme crucial for prostate cancer growth. This discovery offers a novel strategy for developing new CYP17A1 inhibitors to treat prostate cancer.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Computational Biology
Background:
- Androgens, such as testosterone, are vital for prostate cancer progression.
- CYP17A1 is a key enzyme in androgen synthesis and a critical therapeutic target.
- Recent findings suggest a secondary binding site within CYP17A1's substrate entry channel.
Purpose of the Study:
- To characterize the newly identified secondary binding site on CYP17A1.
- To investigate the binding free energy landscape of ligands at this secondary site.
- To explore novel therapeutic strategies for prostate cancer by targeting CYP17A1.
Main Methods:
- Utilized Funnel Metadynamics simulations.
- Calculated binding free energy landscapes for known ligands.
- Analyzed ligand interactions at the secondary binding site.
Main Results:
- Successfully characterized the secondary binding site in the CYP17A1 substrate entry channel.
- Mapped the binding free energy landscape, revealing potential ligand interactions.
- Identified that nonheme-interacting ligands can effectively bind to this site.
Conclusions:
- The identified secondary binding site presents a novel target for drug design.
- Nonheme-interacting ligands offer a promising avenue for developing new CYP17A1 inhibitors.
- This research provides a foundation for novel therapeutic approaches to prostate cancer treatment.
More Related Videos
Related Concept Videos
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
The Equilibrium Binding Constant and Binding Strength
12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K

![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)
